KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019)

Historic Current Taxes for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Q4 2019 value amounting to $8.7 million.

  • Amneal Pharmaceuticals' Current Taxes rose 65314.93% to $8.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $8.7 million, marking a year-over-year increase of 65314.93%. This contributed to the annual value of $8.7 million for FY2019, which is 65314.93% up from last year.
  • According to the latest figures from Q4 2019, Amneal Pharmaceuticals' Current Taxes is $8.7 million, which was up 65314.93% from $1.2 million recorded in Q4 2018.
  • Amneal Pharmaceuticals' 5-year Current Taxes high stood at $8.7 million for Q4 2019, and its period low was $1.2 million during Q4 2018.